Friday, January 25, 2013

Nexstar Broadcasting Group, Inc (NXST) - A New America Folio Position

Nexstar Broadcasting Group, Inc, is a television broadcasting company focused on the acquisition, development, and operation of television stations in medium sized markets in the United States.

Nexstar continues its move higher. As I write, Friday morning, shares have advance over 3.5% so far today.

Market in Confirmed Uptrend

Tuesday, January 22, 2013

Western Digital (WDC) shares were up more than 5% on Tuesday

Western Digital (WDC),  a GWM Core Equity Folio position was up more than 5% on Tuesday afternoon, a day before the disk drive maker is scheduled to release its Q4 earnings results.

Market in Confirmed Uptrend

All Green

Monday, January 14, 2013

China Looking Good

China ETF (GXC)

Two Reasons to Stick With Emerging Market ETFs


After weak performance through much of 2012, emerging markets gained roughly 1% in November and nearly 5% in December.[New Highs for Emerging Market ETFs]

But now many market watchers are wondering whether the emerging market trade is still a smart one.

In my opinion, the answer is a resounding yes. Here are two reasons why I think there’s room for further emerging market gains in 2013.
Mounting evidence of faster growth: The growth outlook for emerging markets has improved in recent months. While China and other large emerging market countries are highly unlikely to achieve double-digit growth anytime soon, or ever, their growth should be higher in 2013.
Take China. The country’s economic outlook has improved significantly over the last few months. As recently as July, China’s exports were growing at a paltry 1% year over year. As of December, exports were growing 14% from a year earlier. Similarly, Chinese manufacturing gauges have picked up recently and Chinese commodity imports (an important sanity check in a country in which official data is often questioned) have sharply accelerated.
The recent improvement in China’s economic outlook is likely to benefit China’s stock market as well as the emerging markets in China’s orbit such as Brazil (China is critical to Brazil’s commodity sector).
The markets are still cheap: Even after the recent rally, emerging market stocks look particularly inexpensive compared to their developed market counterparts, especially considering emerging markets’ improved growth outlook. Based on price-to-earnings ratios, developed markets are trading at a 50% premium to emerging markets, the largest such premium since late 2009. And historically, premiums this large have generally been associated with emerging market outperformance over the next twelve months.

Thursday, January 10, 2013

2013 will be a fantastic year for emerging markets

Mark Mobius
2013 will be a fantastic year for emerging markets according to Mark Mobius, Templeton Fund Manager.

Click the link to view a brief video clip.

Wednesday, January 9, 2013

Urban Outfitters (URBN) was upgraded from Neutral to Outperform

Jan 04, 2013 (SmarTrend(R) Upgrades/Downgrades via COMTEX News Network) --

Urban Outfitters (NASDAQ:URBN) was upgraded from Neutral to Outperform at Credit Suisse today.

Urban Outfitters, Inc. operates retail stores and direct response, including a catalog and Web sites. The Company's Urban Outfitters and Anthropologie retail concepts sell fashion apparel, accessories, and household and gift merchandise. Urban also designs and markets young women's casual wear which it provides to the Company's retail operations and sells to retailers worldwide.

Monday, January 7, 2013

Celegene Rose 4.4% on Big Hopes for 2017

Celgene (CELG) has big plans for 2017. During a presentation Monday at the J.P. Morgan 31st Annual Healthcare Conference in San Francisco, the company said it expects sales to double by 2017 to $12 billion as it benefits from efforts to find new therapies and expand uses for older drugs.
Investors applauded, sending Celgene’s share price to a new 52-week high during afternoon market action. The shares closed today at $85.73, a 4.4% gain over the previous close.

Celgene is one of the largest biotech companies in the U.S., with revenue exceeding $5 billion last year. Much of those sales came from the blood cancer drug Revlimid.

Special Thanks
I need to thank Dr. Jeffrey Scott, cancer Doc and HGSI forum leader, for bringing to our attention the  bright prospects for Celegene , a GWM Core Equity position.

Wednesday, January 2, 2013

The Market Soars on Fiscal Cliff Relief 01 02 2012

Market Snapshot
Transition from
Bear to Bull to Overbought

In Three Trading Days
the market has gone from bearish to bullish
to overbought

Chart View

Market gaps up at open and moves higher
throughout the day.

Woody Indicator
Fear & Greed at Work

Fear came out of the market very fast as investors piled into stocks.

Market Direction Model

The strongest two day move
 in recent memory.
We have two trading days delivering Big Kahunas.
(We call our Impulse Indicators Kahunas)
I added to our equity positions incrementally last Friday and today as the political winds shifted. I will add more equities on pull-backs, probably tomorrow if we do get a pull-back.

I will review these market moves more in-depth in the upcoming issue of The Gerritz Letter.

Fiscal Cliff Disaster Averted - Markets Rally

Daily Market Snapshot

Markets reverse big time.

Chart View

Woody Indicator
Measures Fear & Greed

Volatility as measured by the VIX dropped way back down.
We are very quickly approaching the Safe Zone again.

Market Direction Model

Market in Confirmed Uptrend

Late last night:   In the eleventh hour Congress brings us back from the brink. A Fiscal Cliff deal has been struck. Consequently, futures are up strongly world wide. Our Market Direction Model has been upgraded to Market in Confirmed Uptrend. In other words, it's safe to go back in the water.

This blog post does not constitute an offer of investment advice. This blog is only provided for educational purposes. Please read the Important Blog Disclosure posted in the right channel bar.